United Therapeutics

United Therapeutics is a publicly traded biotechnology company that develops treatments for chronic and life-threatening conditions, with a primary focus on pulmonary arterial hypertension (drugs including Tyvaso, Remodulin and Orenitram). The company also researches organ manufacturing and xenotransplantation to address the shortage of transplantable organs. It is structured as a public benefit corporation and trades on Nasdaq under ticker UTHR.